top of page

DEEP TECH | INDEPENDENT PROGRAMME REVIEW & COMMERCIALISATION STRATEGY​

Decisions that
stand up to scrutiny

Receive an independent recommendation in 2–3 weeks on one consequential decision: what to continue, change, fund or stop – and the evidence needed to defend it.

About-Me-MKWitte.png

The Deep Tech Innovation Friction

A deep tech programme can meet its activity targets during evaluation without clear evidence of producing the intended outcomes. 

​A complex technology can perform well while customer adoption, regulation, delivery or financing blocks its route to market, ultimately causing the Valley of Death.

​

QUATISE® is the proprietary methodology behind my work. It helps me examine how factors – that are usually assessed in silos – affect one another, identify what is limiting progress and turn complex evidence into a decision you can act on

Science Commercialisation:
When Startup Playbook Fails

Innovation programme evaluation for funders and institutions

Before renewing a programme, expanding a portfolio or defending results to a board, you need to know what the evidence supports. I examine outcomes, selection, incentives and delivery to identify what should be retained, redesigned or stopped.​

Typical decisions

→ Is this programme producing enough defensible evidence to receive another funding period?

→ Which parts of the portfolio merit further support?

→ Are the reported outcomes caused by the programme – or mainly by selecting strong participants?

Commercialisation strategy for scaleups and technology-led SMEs

Technical progress, pilots and funding do not automatically lead to paying customers. I examine customer adoption, the route to market and capital requirements together, so you can decide which product, market or financing move deserves your resources next.

Typical decisions

→ Why are successful pilots not becoming repeatable revenue?

→ Which market or customer should we pursue first?

→ What must we prove before the next major investment or funding round?

​​

Our Work
Headshot-Maria-Ksenia-Witte-4.png

Independent expertise.
A clear point of view.

Hi, I'm Maria Ksenia Witte

Scientist and commercialisation expert working independently, connecting science, commercial strategy and capital. Through Arise Innovations®, I help institutions and ventures turn complex evidence into decisions they can act on.

 

250+ cases assessed · 25+ programmes & ecosystems

€100M+ allocation exposure

 

My QUATISE® methodology is built on formally certified applied RD&I under OECD Frascati criteria (validated through the German Federal Ministry of Research, Technology and Space).

Newsletter
Briefs

Get insights on science, commercialisation and capital. No noise, just high-signal research and practical implications for consequential decisions.

bottom of page